Drugs / controlled nitric oxide releasing patch
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00317629 | May 2006 → Jan 2009 | cutaneous leishmaniasis | Fundación Cardiovascular de Colombia | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | controlled nitric oxide releasing patch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00317629 ↗ |
| Known as | NOP | “Upon hydration, this Nitric Oxide Releasing Patch (NOP) produces a stable release of 3.5 µmol of NO during 12 hrs” NCT00317629 ↗ |
| Modality | Other / unclassified | “a multilayer transdermal patch has been produced” NCT00317629 ↗ |